
Long Covid Care Gets a New Evidence Boost as UK Trial Finds Sustained Benefits
UK trial finds specialist long Covid care can reduce fatigue and support recovery, reinforcing the value of structured NHS follow-up.
A broad look at the latest biomedical science and the discoveries driving medicine forward.

UK trial finds specialist long Covid care can reduce fatigue and support recovery, reinforcing the value of structured NHS follow-up.

NHS rolls out a new endometriosis test, raising hopes for faster diagnosis and better care for patients in the UK.

BMJ reports obesity is rising fastest among young adults in England, with widening inequalities since the covid pandemic.

A new McMaster-discovered antibiotic, manikomycin, shows early promise against drug-resistant bacteria by targeting a new ribosome site.

New imaging is helping doctors detect inflammation in heart disease, reshaping cardiovascular risk assessment and treatment.

Ocrelizumab slowed disability progression in advanced progressive MS in a major phase III trial involving more than 1,000 patients.

Rocket Science Health reports a primate study showing targeted olfactory cleft deposition with its intranasal delivery device.

Imperial researchers developed a blood test that may predict disease progression and treatment response in future clinical care.

UK chikungunya cases hit a 10-year high, prompting travel health warnings and renewed clinical vigilance.